Showing results (391-400 of 443) with videos related to
Sort By:
Pageof 45
Antibody Therapeutics|January 11, 2019
Construction and next-generation sequencing analysis of a large phage-displayed VNAR single-domain antibody library from six naïve nurse sharksMingqian Feng, Hejiao Bian, Xiaolin Wu, et al.Cell Stem Cell|August 30, 2016
3D Culture Supports Long-Term Expansion of Mouse and Human Nephrogenic ProgenitorsZhongwei Li, Toshikazu Araoka, Jun Wu, et al.Journal of Hematology & Oncology|February 25, 2021
Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trialRobert J Kreitman, Claire Dearden, Pier Luigi Zinzani, et al.Cancer Immunity|December 20, 2007
Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelinRaffit Hassan, Wolfgang Ebel, Eric L Routhier, et al.Cancer|September 2, 2020
Phase 1 study of the immunotoxin LMB-100 in patients with mesothelioma and other solid tumors expressing mesothelinRaffit Hassan, Christine Alewine, Idrees Mian, et al.Frontiers in Oncology|May 6, 2024
Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancersNebojsa Skorupan, Cody J Peer, Xianyu Zhang, et al.Scientific Reports|January 9, 2021
Identification of the atypical cadherin FAT1 as a novel glypican-3 interacting protein in liver cancer cellsPanpan Meng, Yi-Fan Zhang, Wangli Zhang, et al.Journal of Cancer|October 6, 2010
Mesothelin as a potential therapeutic target in human cholangiocarcinomaLiping Yu, Mingqian Feng, Heungnam Kim, et al.Molecular Oncology|August 11, 2016
Characterization of a re-engineered, mesothelin-targeted Pseudomonas exotoxin fusion protein for lung cancer therapyFrieder Bauss, Martin Lechmann, Ben-Fillippo Krippendorff, et al.Plos Pathogens|January 14, 2014
Targeted cytotoxic therapy kills persisting HIV infected cells during ARTPaul W Denton, Julie M Long, Stephen W Wietgrefe, et al.Pageof 45